๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association

โœ Scribed by Silvia Fargion; Alberto Piperno; Maria Domenica Cappellini; Maurizio Sampietro; Anna Ludovica Fracanzani; Riccardo Romano; Rita Caldarelli; Rosaria Marcelli; Luisa Vecchi; Gemino Fiorelli


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
604 KB
Volume
16
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

โœฆ Synopsis


Porphyria cutanea tarda in human beings is believed to be due to reduced hepatic uroporphyrinogen decarboxylase activity. However, extrinsic factors such as alcohol abuse and drug intake are required for clinical manifestation of the disease. In addition to typical cutaneous lesions, patients with porphyria cutanea tarda usually have chronic liver disease and moderate iron overload. Of 74 Italian patients with porphyria cutanea tarda, hepatitis C virus antibodies were detected in 76% by enzyme-linked immunoassay and in 82% by recombinant immunoblot assay. Viral genome, studied with nested polymerase chain reaction, was found in the sera of 49 subjects--47 positive and 2 indeterminate on recombinant immunoblot assay. Five percent of the patients were HBsAg-positive, and about 40% had had past hepatitis B contacts. Alcohol abuse was present in 38%. Liver biopsies performed in 42 patients showed chronic persistent hepatitis in 7 patients, chronic active hepatitis in 22 patients, fibrosis in three patients and cirrhosis in 10 patients. Hepatitis C virus antibody was detected in 100% of patients with chronic active hepatitis and in about 80% of all other groups. Alcohol abuse was more frequent in patients with cirrhosis (80%) than in the other groups. In Italian patients with porphyria cutanea tarda, the prevalence of hepatitis C virus infection was very high, comparable to that in non-A, non-B hepatitis and high-risk patient groups. Hepatitis C virus is probably the main pathogenetic factor of the liver disease of patients with porphyria cutanea tarda.


๐Ÿ“œ SIMILAR VOLUMES


Hepatitis C virus antibodies and liver d
โœ Mar Decastro; Javier Sรกnchez; Jesรบs F. Herrera; Asunciรณn Chรกves; Rafael Durรกn; L ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 1011 KB

The recent identification of the hepatitis C virus and development of assays to detect antibodies to hepatitis C virus has allowed assessment of the prevalence of hepatitis C virus infection in patients with a variety of liver and other diseases. The aim of this study was to investigate the prevalen

Low prevalence of hepatitis C virus infe
โœ Ulrich Stรถlzel; Erich Kรถstler; Christiane Koszka; Maricka Stรถffler-Meilicke; Det ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 431 KB ๐Ÿ‘ 1 views

Previous studies from Spain, Italy, and France have demonstrated a high prevalence (71% to 91%) of antibodies against hepatitis C virus in patients with porphyria cutanea tarda (PCT). To determine the role of hepatitis C virus (HCV) in PCT in Germany, we have assessed the prevalence of antibodies ag

Hepatic uroporphyrinogen decarboxylase a
โœ Maria Jose Moran; Antonio Fontanellas; Eric Brudieux; Isabelle Hombrados; Victor ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 85 KB

Porphyria cutanea tarda (PCT) is caused by a decreased activity of the hepatic enzyme uroporphyrinogen decarboxylase (URO-D). This deficiency causes overproduction, hepatic deposition, and increased excretion of uroporphyrin. Iron overload and hepatic viral infections are considered aggravating fact

Epidemiology of hepatitis C and G in spo
โœ Jรฉrรดme Lamoril; Christophe Andant; Catherine Bogard; Hervรฉ Puy; Laurent Gouya; J ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 65 KB ๐Ÿ‘ 1 views

From 1995 to 1997, we prospectively evaluated the prevalence of hepatitis C virus (HCV) RNA in 124 patients with porphyria cutanea tarda (PCT) from Northern France (83 sporadic and 41 familial PCT). Serum samples were analyzed for ferritin, transaminases, HCV antibodies, and HCV RNA. In addition, ge

Detection of hepatitis C virus by polyme
โœ Pietro Andreone; Carmela Cursaro; Annagiulia Gramenzi; Maria Silvia Guidetti; Fr ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 252 KB ๐Ÿ‘ 1 views

In situ demonstration of Epstein-Barr virus small RNAs (EBERI) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site.